177 related articles for article (PubMed ID: 33804080)
1. The Effect of Small Molecule Pharmacological Agents on the Triterpenoid Saponin Induced Endolysosomal Escape of Saporin and a Saporin-Based Immunotoxin in Target Human Lymphoma Cells.
Wensley HJ; Smith WS; Holmes SE; Flavell SU; Flavell DJ
Biomedicines; 2021 Mar; 9(3):. PubMed ID: 33804080
[TBL] [Abstract][Full Text] [Related]
2. A Flow Cytometric Method to Quantify the Endosomal Escape of a Protein Toxin to the Cytosol of Target Cells.
Wensley HJ; Johnston DA; Smith WS; Holmes SE; Flavell SU; Flavell DJ
Pharm Res; 2019 Dec; 37(1):16. PubMed ID: 31873810
[TBL] [Abstract][Full Text] [Related]
3. The Role of Cholesterol on Triterpenoid Saponin-Induced Endolysosomal Escape of a Saporin-Based Immunotoxin.
Smith WS; Johnston DA; Wensley HJ; Holmes SE; Flavell SU; Flavell DJ
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33228031
[TBL] [Abstract][Full Text] [Related]
4. Augmentation of Saporin-Based Immunotoxins for Human Leukaemia and Lymphoma Cells by Triterpenoid Saponins: The Modifying Effects of Small Molecule Pharmacological Agents.
Smith WS; Johnston DA; Holmes SE; Wensley HJ; Flavell SU; Flavell DJ
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30791598
[TBL] [Abstract][Full Text] [Related]
5. Triterpenoid saponin augmention of saporin-based immunotoxin cytotoxicity for human leukaemia and lymphoma cells is partially immunospecific and target molecule dependent.
Holmes SE; Bachran C; Fuchs H; Weng A; Melzig MF; Flavell SU; Flavell DJ
Immunopharmacol Immunotoxicol; 2015 Feb; 37(1):42-55. PubMed ID: 25347443
[TBL] [Abstract][Full Text] [Related]
6. Membrane cholesterol is essential for triterpenoid saponin augmentation of a saporin-based immunotoxin directed against CD19 on human lymphoma cells.
Smith WS; Baker EJ; Holmes SE; Koster G; Hunt AN; Johnston DA; Flavell SU; Flavell DJ
Biochim Biophys Acta Biomembr; 2017 May; 1859(5):993-1007. PubMed ID: 28235471
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of saporin cytotoxicity by Gypsophila saponins--more than stimulation of endocytosis.
Weng A; Bachran C; Fuchs H; Krause E; Stephanowitz H; Melzig MF
Chem Biol Interact; 2009 Oct; 181(3):424-9. PubMed ID: 19615984
[TBL] [Abstract][Full Text] [Related]
8. Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy.
Bostad M; Olsen CE; Peng Q; Berg K; Høgset A; Selbo PK
J Control Release; 2015 May; 206():37-48. PubMed ID: 25758331
[TBL] [Abstract][Full Text] [Related]
9. The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure.
Bachran C; Sutherland M; Heisler I; Hebestreit P; Melzig MF; Fuchs H
Exp Biol Med (Maywood); 2006 Apr; 231(4):412-20. PubMed ID: 16565437
[TBL] [Abstract][Full Text] [Related]
10. Saponins from Saponaria officinalis L. Augment the Efficacy of a Rituximab-Immunotoxin.
Gilabert-Oriol R; Thakur M; Haussmann K; Niesler N; Bhargava C; Görick C; Fuchs H; Weng A
Planta Med; 2016 Dec; 82(18):1525-1531. PubMed ID: 27392242
[TBL] [Abstract][Full Text] [Related]
11. Saponins modulate the intracellular trafficking of protein toxins.
Weng A; Thakur M; von Mallinckrodt B; Beceren-Braun F; Gilabert-Oriol R; Wiesner B; Eichhorst J; Böttger S; Melzig MF; Fuchs H
J Control Release; 2012 Nov; 164(1):74-86. PubMed ID: 23063550
[TBL] [Abstract][Full Text] [Related]
12. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
13. Host-mediated antibody-dependent cellular cytotoxicity contributes to the in vivo therapeutic efficacy of an anti-CD7-saporin immunotoxin in a severe combined immunodeficient mouse model of human T-cell acute lymphoblastic leukemia.
Flavell DJ; Warnes S; Noss A; Flavell SU
Cancer Res; 1998 Dec; 58(24):5787-94. PubMed ID: 9865737
[TBL] [Abstract][Full Text] [Related]
14. Targeted delivery and enhanced cytotoxicity of cetuximab-saporin by photochemical internalization in EGFR-positive cancer cells.
Yip WL; Weyergang A; Berg K; Tønnesen HH; Selbo PK
Mol Pharm; 2007; 4(2):241-51. PubMed ID: 17263556
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A-chain immunotoxins on murine liver parenchymal cells.
Blakey DC; Skilleter DN; Price RJ; Watson GJ; Hart LI; Newell DR; Thorpe PE
Cancer Res; 1988 Dec; 48(24 Pt 1):7072-8. PubMed ID: 3263899
[TBL] [Abstract][Full Text] [Related]
16. Modified trastuzumab and cetuximab mediate efficient toxin delivery while retaining antibody-dependent cell-mediated cytotoxicity in target cells.
Gilabert-Oriol R; Thakur M; von Mallinckrodt B; Hug T; Wiesner B; Eichhorst J; Melzig MF; Fuchs H; Weng A
Mol Pharm; 2013 Nov; 10(11):4347-57. PubMed ID: 24050452
[TBL] [Abstract][Full Text] [Related]
17. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the performance of anti-CD7 and anti-CD38 bispecific antibodies and immunotoxins for the delivery of saporin to a human T-cell acute lymphoblastic leukemia cell line.
Flavell DJ; Cooper S; Okayama K; Emery L; Flavell SU
Hematol Oncol; 1995; 13(4):185-200. PubMed ID: 7557895
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the potency and therapeutic efficacy of the anti-CD7 immunotoxin HB2-saporin constructed with one or two saporin moieties per immunotoxin molecule.
Flavell DJ; Boehm DA; Noss A; Flavell SU
Br J Cancer; 1997; 75(7):1035-43. PubMed ID: 9083340
[TBL] [Abstract][Full Text] [Related]
20. Combined application of saponin and chimeric toxins drastically enhances the targeted cytotoxicity on tumor cells.
Heisler I; Sutherland M; Bachran C; Hebestreit P; Schnitger A; Melzig MF; Fuchs H
J Control Release; 2005 Aug; 106(1-2):123-37. PubMed ID: 15935506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
